RxDoctor Payments Data

Amy Harrison

Family · Indianapolis, INNPI 1265035422

Payments from drug & device makers

$464in general payments, 2019–2025

Across 23 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$103
  • Otsuka America Pharmaceutical, Inc.$81
  • Exact Sciences$55
  • Astellas Pharma US Inc$54
  • Pfizer$37
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$36
  • plus $99 from 5 others

What the payments were for

  • Food & beverage$464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$13,869
Medicare patients
88
Services billed
171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$41,874
TrulicityDulaglutide20$31,294
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$19,298
XareltoRivaroxaban15$13,541
TradjentaLinagliptin11$8,722
Albuterol Sulfate HfaAlbuterol Sulfate60$1,850
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,474
Fenofibrate17$1,446
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$1,098
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$1,051
Levothyroxine Sodium61$995
Atorvastatin Calcium129$921
Metoprolol Succinate52$803
Levetiracetam14$740
Amlodipine Besylate106$736

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$41,87435 claims
Lilly USA, LLCTrulicity, Olanzapine$17$31,90042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,392 family providers in Indiana.

Other family in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →